Type 1 diabetes (T1DM) is a disease with an important socio-economic impact, caused by autoimmune destruction of pancreatic insulin producing cells (β-cells) and associated with development of debilitating macrovascular and microvascular complications [1]. This evidence concerns the gene INS and type 1 diabetes mellitus.